FDU-PB-22

FDU-PB-22_structure.png

FDU-PB-22 is a synthetic cannabinoid that has been used in scientific research and has been sold online as a designer drug. It is a potent agonist of the cannabinoid receptors, which are part of the endocannabinoid system.

Chemical Structure

FDU-PB-22 is chemically classified as an indole-based synthetic cannabinoid. Its full chemical name is quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate. The structure of FDU-PB-22 includes a fluoropentyl chain, which is a common feature in many synthetic cannabinoids, contributing to its high potency.

Pharmacology

FDU-PB-22 acts as a potent agonist at the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including pain sensation, mood, and appetite. The binding affinity of FDU-PB-22 to these receptors is high, which accounts for its strong psychoactive effects.

Legal Status

The legal status of FDU-PB-22 varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. For example, in the United States, it is listed as a Schedule I controlled substance under the Controlled Substances Act.

Health Effects and Risks

The use of FDU-PB-22 has been associated with a range of adverse health effects. These can include tachycardia, hypertension, nausea, vomiting, and anxiety. Due to its high potency, there is a significant risk of overdose, which can lead to severe health complications or death.

Research and Applications

FDU-PB-22 has been used in scientific research to study the endocannabinoid system and the effects of synthetic cannabinoids. However, due to its potential for abuse and adverse health effects, its use is highly regulated and often restricted to laboratory settings.

See Also

• Synthetic cannabinoids
• Cannabinoid receptor
• Endocannabinoid system
• Designer drug